4.7 Article

RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity

Journal

BRIEFINGS IN BIOINFORMATICS
Volume 23, Issue 2, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbab561

Keywords

prediction modelling; cancer; transcriptomics; radiation therapy; radiosensitivity

Funding

  1. UKRI Future Leaders Fellowship [MR/T021721/1]

Ask authors/readers for more resources

This study presents a comprehensive benchmarking framework for radio sensitivity (RS) signatures, evaluating multiple published signatures and comparing them to control signatures. The results show that both published and cellular process signatures have limited radiation-specific information. Therefore, improved modeling strategies are needed to predict intrinsic RS accurately.
Multiple transcriptomic predictors of tumour cell radiosensitivity (RS) have been proposed, but they have not been benchmarked against one another or to control models. To address this, we present RadSigBench, a comprehensive benchmarking framework for RS signatures. The approach compares candidate models to those developed from randomly resampled control signatures and from cellular processes integral to the radiation response. Robust evaluation of signature accuracy, both overall and for individual tissues, is performed. The NCI60 and Cancer Cell Line Encyclopaedia datasets are integrated into our workflow. Prediction of two measures of RS is assessed: survival fraction after 2 Gy and mean inactivation dose. We apply the RadSigBench framework to seven prominent published signatures of radiation sensitivity and test for equivalence to control signatures. The mean out-of-sample R-2 for the published models on test data was very poor at 0.01 (range: -0.05 to 0.09) for Cancer Cell Line Encyclopedia and 0.00 (range: -0.19 to 0.19) in the NCI60 data. The accuracy of both published and cellular process signatures investigated was equivalent to the resampled controls, suggesting that these signatures contain limited radiation-specific information. Enhanced modelling strategies are needed for effective prediction of intrinsic RS to inform clinical treatment regimes. We make recommendations for methodological improvements, for example the inclusion of perturbation data, multiomics, advanced machine learning and mechanistic modelling. Our validation framework provides for robust performance assessment of ongoing developments in intrinsic RS prediction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available